Abstract
Anticoagulation with warfarin may fail to achieve the therapeutic target of the international normalized ratio (INR) in >30% of patients.1 This study examined the prevalence of intra-atrial thrombi in patients with atrial fibrillation (AF) who received warfarin for ≥3 weeks but had a subtherapeutic INR.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
